Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Onxeo Adjusts Direction With Acquisition Of DNA-Repair Interference Platform

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm that was focused on technology to reformulate old drugs gains platform for novel drugs that will induce cell death in orphan oncology indications.



Related Companies

Related Deals